Tag

Statins

All articles tagged with #statins

health5 days ago•38 min saved

New Study Links Statin Use to Reduced Risk of Glaucoma and Vision Loss

A large observational study from UC San Diego suggests that statins, commonly prescribed for cholesterol, may significantly reduce the risk of developing glaucoma and the need for eye surgery. Analyzing over 210,000 patients, researchers found that statin users had a 15% lower risk of open-angle glaucoma and up to a 60% lower risk of requiring laser treatments. While the findings are promising, experts emphasize that the study is observational and cannot prove causation, noting that further clinical trials are needed to confirm these protective effects.

via Good News Network|

#cholesterol #eye-health #glaucoma

health11 days ago

New US Guidelines Expand Statin Eligibility to 87.5 Million Adults

The American Heart Association has updated its cholesterol guidelines, expanding the age range for cardiovascular risk assessment from 40-75 to 30-79. This change now qualifies approximately 87.5 million Americans, or more than half of adults in that age bracket, for potential statin treatment. The update includes a 21.5 million increase in eligible patients since the 2018 guidelines. While statins effectively lower 'bad' LDL cholesterol by 30-50%, experts emphasize that medication is not a substitute for lifestyle changes. The new framework aims to identify risk earlier, potentially preventing arterial plaque formation before it becomes irreversible, though long-term data on starting medication in one's 30s remains limited.

via The Telegraph|

#american-heart-association #cardiovascular-health #cholesterol

health25 days ago•4 min saved

GLP-1 Boom Does Not Replace Statins in Cardiovascular Care

Despite the rapid rise of GLP-1 receptor agonists for weight loss, statins remain the first-line treatment for lowering LDL cholesterol and reducing cardiovascular risk. Experts emphasize that these therapies address different metabolic targets and are often complementary rather than competing. Recent FDA approvals for tirzepatide and new guidelines lowering the age for lipid assessment to 30 reinforce the continued necessity of statins, even as GLP-1 drugs account for nearly 8% of US prescriptions.

via Medscape|

#cardiology #glp-1-agonists #health

health1 month ago•9 min saved

Statin use in healthy adults and diabetics may lower dementia risk, but evidence remains mixed

Recent studies suggest statins may offer cognitive benefits beyond heart protection. A Danish observational study found a 15% lower dementia risk for type 2 diabetes patients starting statins early, while a Monash University trial showed a 30% reduction in major heart events for healthy seniors over 70, though no improvement in disability-free survival was observed. Experts caution that observational data is prone to bias and that individual risk assessment is crucial.

via The Conversation|

#cardiovascular-disease #dementia #health

health1 month ago•4 min saved

Danish Study Links Early Statin Use to 15% Lower Dementia Risk in Diabetics

A large observational study in Denmark found that starting statin therapy within one year of a type 2 diabetes diagnosis is associated with a 15% lower relative risk of dementia over a decade. While the study does not prove causation, researchers suggest that early cholesterol management may offer neuroprotective benefits beyond cardiovascular care.

via ScienceAlert|

#cardiovascular-health #dementia #health

health1 month ago•47 min saved

Geriatrician links rising dementia risk to vascular factors, flags post‑diabetes statins as key prevention

A geriatrician warns of a growing dementia epidemic and says starting statins soon after a type 2 diabetes diagnosis may lower dementia risk, especially vascular dementia, though the cited study does not prove causation.

via yahoo.com|

#dementia #diabetes #health

health1 month ago•4 min saved

Danish study links early statin use in diabetics to 15% lower dementia risk

A large observational study of 132,585 Danish patients with type 2 diabetes found that starting statin therapy within one year of diagnosis was associated with a 15% lower relative risk of developing dementia over a 10-year period. Those who delayed treatment by one to five years still saw a 10% risk reduction. The findings, presented at the European Society of Cardiology Congress and published in The Lancet Regional Health – Europe, suggest that early cholesterol management may protect brain health by reducing vascular inflammation, though the study does not prove causation.

via Fox News|

#cardiology #dementia #health

health1 month ago•0 min saved

Statins Linked to 15% Lower Dementia Risk in Large Danish Study

A 15-year observational study of over 132,000 Danish patients with type 2 diabetes suggests that starting statins early in life reduces the risk of developing dementia by 15%, while later initiation lowers risk by 10%. Presented at the European Society of Cardiology (ESC) Congress 2026, the findings indicate that managing low-density lipoprotein (LDL) cholesterol may protect brain health by preventing vascular damage. While experts emphasize that statins are widely available and inexpensive, they caution that observational data cannot prove causation. Concurrently, the STAREE trial reported that atorvastatin reduces major cardiovascular events by 30% in adults over 70, though it did not show a significant reduction in dementia incidence. These results reinforce the link between cardiovascular health and brain function, suggesting that early cholesterol management could be a key strategy in preventing or delaying dementia, which is forecast to affect 153 million people globally by 2050.

via The Guardian|

#cardiovascular-health #dementia #esc-2026

health1 month ago•3 min saved

Healthy seniors over 70 may gain protection from daily statins, trial shows

A world-first randomized trial in nearly 10,000 Australians over 70 without prior heart disease found that daily statin use reduced the risk of a first major cardiovascular event by 30% over about six years, with one event prevented for every 37 people treated. The study, published in the New England Journal of Medicine and presented at the European Society of Cardiology Congress, suggests older adults should discuss statin therapy with their GP; side effects were low and dementia risk did not increase, but adherence was an issue and results may not generalize to all populations.

via The Guardian|

#australia #cardiovascular-disease #elderly

health1 month ago•8 min saved

Calcium score tests rarely change heart-risk decisions, study finds

A JAMA study of about 6,000 adults shows the PREVENT heart-disease risk calculator alone accurately predicts near-term events for most people; adding a coronary artery calcium (CAC) score provides little extra value except as a tiebreaker for those at borderline/intermediate risk, where a higher CAC score may influence statin decisions. For high- or low-risk individuals, CAC typically wouldn’t alter treatment, suggesting CAC scans should be reserved for select middle-risk patients and discussed with a clinician.

via The Washington Post|

#cac-scan #calcium-scoring #health

health2 months ago•62 min saved

Cardiologists Say CoQ10 Is Usually a Waste—Choose Diet, Exercise, Sleep Instead

Cardiologists warn that CoQ10 supplements offer uncertain value for heart health and can interfere with medications like warfarin and diabetes drugs, making them a questionable use of time and money. They urge evidence-based lifestyle changes—eat a heart-healthy diet (Mediterranean/DASH), aim for at least 150 minutes of aerobic activity plus resistance training each week, and prioritize sleep—as more reliable ways to protect the heart, noting CoQ10 may have niche use only under medical supervision or in very specific deficiencies.

via AOL.com|

#cardiology #coq10 #health

health2 months ago•3 min saved

Very High LDL Triggers Aggressive Statin Therapy, Roach Says

In a health Q&A, Dr. Roach explains that an LDL over 190 mg/dL carries high cardiovascular risk, so statin therapy is recommended—even for younger patients—though the dose is debated. A patient on rosuvastatin 40 mg plus ezetimibe is reasonable, but many clinicians tailor dosing to reach LDL goals (often <70 mg/dL) by starting lower and titrating. In a second question, diet sodas can erode tooth enamel and may influence gut microbiome and future glucose control; they don’t reliably raise A1C in the short term, but water is best, with sugar-sweetened beverages worse for health.

via The Detroit News|

#cholesterol #diet-soda #ezetimibe

health2 months ago•61 min saved

Guideline Shift Expands Statin Eligibility to 87.5 Million Americans

A JAMA analysis of the 2026 ACC/AHA cholesterol guidelines shows 21.5 million more U.S. adults now qualify for statins, bringing the total to about 87.5 million. The expansion focuses on long-term lifetime risk rather than just 10-year risk, with older adults and people with risk factors more likely to qualify. Whether to start a statin should be individualized, possibly aided by tests like coronary calcium scoring, alongside lifestyle changes; statins are generally safe with mostly minor side effects.

via AOL.com|

#cardiovascular-disease #cholesterol #guidelines

health2 months ago•6 min saved

Stopping Statins at 75: French Trial Suggests Possible Safety for Healthy Seniors

A French randomized trial in healthy adults around age 80 found that stopping statins at age 75 did not worsen three-year outcomes compared with continuing them; LDL rose after stopping, but death rates and major cardiovascular events were similar and quality of life remained unchanged. The findings may apply only to low-risk, healthy elderly populations and should not change practice broadly; decisions should be individualized and confirmed with longer follow-up and diverse populations.

via STAT|

#cardiovascular-disease #deprescribing #elderly

health2 months ago•3 min saved

Viagra's Secret: Sildenafil May Slow Cancer Spread by Blocking Cellular Cholesterol

A Weizmann Institute study (with U.S. data) suggests sildenafil (Viagra) can limit cancer’s ability to metastasize by disrupting cholesterol use inside cells via PDE5 inhibition and higher cGMP; researchers propose combining Viagra-related drugs with statins to slow spread. However, findings are observational and based on mouse data, so not yet proven in humans.

via LiveNOW from FOX|

#cancer-metastasis #cholesterol #health